Skip to main content
. Author manuscript; available in PMC: 2014 Jul 11.
Published in final edited form as: ACS Med Chem Lett. 2013 May 20;4(7):616–621. doi: 10.1021/ml400112h

Figure 3.

Figure 3

Pharmacokinetics of TG6-129. The compound was administered to mice by i.p. (5 mg/kg) or p.o. (10 mg/kg) route for pharmacokinetics. Compound concentrations in plasma (ng/ml) were measured at different time points. Data are shown as mean ± SEM (n = 3 mice per time point).